Tien Dam

Trial of Cinpanemab in Early Parkinson’s Disease

Anthony E. Lang, Andrew Siderowf, Eric A. Macklin et al. · New England Journal of Medicine · 2022 · 309 citations · Full text

Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial

Adam L. Boxer, Irfan Qureshi, Michael K. Ahlijanian et al. · The Lancet Neurology · 2019 · 137 citations

Dose Phase 1B, Translational Medicine, Clinical Trials +3

Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

Tien Dam, Adam L. Boxer, Lawrence I. Golbe et al. · Nature Medicine · 2021 · 131 citations

Rheumatology, Progressive Supranuclear Palsy, Placebo-controlled Trial +3

Relative Meaningfulness and Impacts of Symptoms in People with Early-Stage Parkinson’s Disease

Jennifer R. Mammen, Rebecca M. Speck, Glenn T. Stebbins et al. · Journal of Parkinson s Disease · 2023 · 40 citations · Full text

Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson’s Disease

Jennifer R. Mammen, Rebecca M. Speck, Glenn M. Stebbins et al. · Journal of Parkinson s Disease · 2023 · 33 citations · Full text